However, some limitations in this study cannot be ignored
Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes, 2012
Managing Expectations and Celebrating Plateau Stability Reaching a plateau is actually a success marker: it means your body has achieved a new, lower, stable weight that the medication is actively maintaining
Beyond these primary endpoints, TRIUMPH-1 includes a range of secondary and exploratory endpoints that paint a fuller picture of retatrutide's clinical impact: Proportion of participants achieving 10%, 15%, and 20% or greater weight loss Changes in waist circumference Changes in cardiometabolic risk factors, including blood pressure, triglycerides, HDL cholesterol, LDL cholesterol, and fasting glucose Changes in HbA1c (a measure of average blood sugar over the preceding two to three months) Changes in liver enzymes and markers of hepatic health Patient-reported outcomes related to quality of life and physical function Safety and tolerability, including the incidence and severity of adverse events The secondary endpoints are particularly important for retatrutide because the Phase 2 data showed striking improvements across metabolic markers
Once mixed the formula will be stable for 3 months refrigerated
I think that you will find most successful PA patients treat their symptoms - they take enough often enough to see the symptoms recede and can then balance it from there
